DNA Ginkgo Bioworks Holdings, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Ginkgo Bioworks Holdings, Inc. (DNA) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 26, 2026, a 10-Q quarterly report filed on May 7, 2026, an 8-K current report filed on August 5, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Ginkgo Bioworks Holdings, Inc. (DNA) (SEC CIK 1830214), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Ginkgo Bioworks Holdings, Inc.
Ask AI about DNA filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting DNA positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on DNA.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Ginkgo Bioworks Holdings, Inc. (DNA) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Aug 5, 2026 | - | - | - |
8-K | Jul 30, 2026 | - | - | - |
8-K | Jun 12, 2026 | - | - | - |
8-K | May 7, 2026 | - | - | |
10-Q | May 7, 2026 | Mar 31, 2026 | - | |
8-K | Apr 7, 2026 | - | - | - |
8-K | Feb 27, 2026 | - | Analysis | - |
8-K | Feb 26, 2026 | - | Analysis | - |
10-K | Feb 26, 2026 | Dec 31, 2025 | - | |
8-K | Dec 23, 2025 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
10-Q | May 6, 2025 | Mar 31, 2025 | - | |
10-K | Feb 25, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | - | |
10-Q | May 9, 2024 | Mar 31, 2024 | - | |
10-K | Feb 29, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | - | |
10-Q | May 10, 2023 | Mar 31, 2023 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q2 2024Aggregate DNA share value held by 13F filers tracked by SignalX, by quarter.
Source: 13F-HR filings on SEC EDGAR (aggregated from 21 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest DNA SEC filings in 2026?
Ginkgo Bioworks Holdings, Inc. (DNA) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did DNA file its most recent 10-K annual report?
Ginkgo Bioworks Holdings, Inc. (DNA) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view DNA 10-Q quarterly reports?
Ginkgo Bioworks Holdings, Inc. (DNA)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every DNA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has DNA filed recently?
Ginkgo Bioworks Holdings, Inc. (DNA)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find DNA insider trading activity (Form 4)?
SignalX aggregates every DNA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does DNA file with the SEC?
Ginkgo Bioworks Holdings, Inc. (DNA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DNA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Ginkgo Bioworks Holdings, Inc. (DNA).
What is DNA's SEC CIK number?
Ginkgo Bioworks Holdings, Inc. (DNA)'s SEC CIK (Central Index Key) number is 1830214. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1830214 to look up all DNA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Ginkgo Bioworks Holdings, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 21+ filings.